AIChE Spring Meeting and Global Congress on Process Safety
April 20, 2021
Natural gas liquefaction requires large refrigeration compressors to achieve volume reduction specifications for transportation of Liquified Natural...
Greg joined Sangamo Therapeutics in 2020 as Vice President of Genome Engineering. He leads teams responsible for the discovery and optimization of novel zinc finger proteins (ZFPs), enabling their translation into genomic medicines. Greg has spent over 20 years in academia and biotech, working in the areas of genome editing, cell engineering, and directed protein evolution. In 2004 at Sigma-Aldrich, Greg’s team collaborated with the lab of Alan Lambowitz (Univ. Of Texas, Austin) to develop RNA-guided systems for bacterial genome editing based on group II introns (...Read more